azacitidine has been researched along with unc 0638 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Agirre, X; de Miguel, I; Fernandez Perez, R; Fraga, M; Garate, L; García-Barchino, MJ; Liu, Y; Martínez-Climent, JA; Miranda, E; Ordoñez, R; Oyarzabal, J; Prosper, F; Rabal, O; Roa, S; Sáez, E; San José-Enériz, E; Sánchez-Arias, JA; Santamarina, P; Ugarte, A; Vilas-Zornoza, A; Wu, W; Xu, M | 1 |
| Chiba, DE; Dos Santos, JL; Lopes, JR | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for azacitidine and unc 0638
| Article | Year |
|---|---|
HIV latency reversal agents: A potential path for functional cure?
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Molecular Structure; Virus Latency | 2021 |
2 other study(ies) available for azacitidine and unc 0638
| Article | Year |
|---|---|
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Modification Methylases; Drug Design; Enzyme Inhibitors; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Mice; Molecular Docking Simulation; Protein Conformation; Xenograft Model Antitumor Assays | 2018 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |